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ABSTRACT 
Motivation: To date, Gene Set Analysis (GSA) approaches primari-
ly focus on identifying differentially expressed gene sets (pathways). 
Methods for identifying differentially coexpressed pathways also 
exist but are mostly based on aggregated pairwise correlations, or 
other pairwise measures of coexpression. Instead, we propose 
Gene Sets Net Correlations Analysis (GSNCA), a multivariate differ-
ential coexpression test that accounts for the complete correlation 
structure between genes. 
Results: In GSNCA, weight factors are assigned to genes in propor-
tion to the genes’ cross-correlations (intergene correlations). The 
problem of finding the weight vectors is formulated as an eigenvec-
tor problem with a unique solution. GSNCA tests the null hypothesis 
that for a gene set there is no difference in the weight vectors of the 
genes between two conditions. In simulation studies and the anal-
yses of experimental data, we demonstrate that GSNCA, indeed, 
captures changes in the structure of genes’ cross-correlations rather 
than differences in the averaged pairwise correlations. Thus, 
GSNCA infers differences in coexpression networks, however, by-
passing method-dependent steps of network inference. As an addi-
tional result from GSNCA, we define hub genes as genes with the 
largest weights and show that these genes correspond frequently to 
major and specific pathway regulators, as well as to genes that are 
most affected by the biological difference between two conditions. In 
summary, GSNCA is a new approach for the analysis of differentially 
coexpressed pathways that also evaluates the importance of the 
genes in the pathways, thus providing unique information that may 
result in the generation of novel biological hypotheses. 
Contact: gvglazko@uams.edu 
Supplementary information: Supplementary data are available at 
Bioinformatics online. 
1 INTRODUCTION  
Large-scale biological research, including genetic link-
age/association studies, copy number variation, microarray and 
RNA-Seq expression experiments, typically compare two or more 
different phenotypes to infer a unique genetic background, associ-
ated with a particular phenotype. A decade ago, the methods for 
such analyses were dominated by univariate two-sample statistical 
tests, which frequently fell short from a statistical and a biological 
  
*To whom correspondence should be addressed.  
perspective because of two reasons. First, small changes in expres-
sion cannot be captured for a single gene using two-sample tests 
(e.g. t-statistic) with the correction for multiple testing (Mootha, et 
al., 2003). Second, genes do not work in isolation but interact with 
each other collectively; as a consequence, statistical tests need to 
account for a multivariate nature of expression changes (Emmert-
Streib and Glazko, 2011; Glazko and Emmert-Streib, 2009). These 
shortcomings catalyzed the appearance of conceptually new meth-
odologies for the analysis of genomic data. Instead of considering 
a single gene as an expression unit, new methodologies started to 
operate with gene sets (corresponding, e.g., to biological path-
ways), considering a gene set as the unit of expression. The first 
test of this kind was the Gene Set Enrichment Analysis, GSEA 
(Mootha, et al., 2003). To date many methodologies for testing the 
differential expression of gene sets (molecular pathways, biologi-
cal processes) have been suggested and are collectively named 
Gene Set Analysis (GSA) approaches (Ackermann and Strimmer, 
2009; Dinu, et al., 2009; Emmert-Streib and Glazko, 2011; Huang 
da, et al., 2009). GSA approaches can be either competitive or self-
contained. Competitive approaches compare a gene set against its 
complement that contains all genes except genes in the set, and 
self-contained approaches compare whether a gene set is differen-
tially expressed between two phenotypes (Goeman and Buhlmann, 
2007; Tian, et al., 2005). Unfortunately, some competitive GSA 
approaches are influenced by the genomic coverage and the filter-
ing of the data and can increase their power by the addition of 
unrelated data and even noise (Tripathi, et al., 2013). Due to these 
problems, we focus in this paper on self-contained methods only. 
Self-contained approaches, depending on the statistics used for the 
testing, test different null hypotheses (Emmert-Streib and Glazko, 
2011; Glazko and Emmert-Streib, 2009; Rahmatallah, et al., 2012). 
The possibility to formulate different statistical hypotheses enables 
the formulation and exploration of different biological hypotheses. 
However, for GSA approaches, testing hypotheses other than the 
equality of the mean expression vectors, remains underexplored. 
We recently suggested to extend a univariate analysis of differen-
tial gene variability (Ho, et al., 2008) to a multivariate case of gene 
sets (Rahmatallah, et al., 2012) with a multivariate non-parametric 
‘radial’ Kolmogorov–Smirnov (RKS) test, sensitive to alternatives 
that have similar mean vectors, but are different in their scale 
(Friedman and Rafsky, 1979). We found that for several tumor 
types, the pathways, detected exclusively by the RKS test, were 
mostly tumor-specific, while the pathways with differences in the 
Associate Editor: Dr. Janet Kelso
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2 
mean expression vectors were detected simultaneously in different 
tumor types (Rahmatallah, et al., 2012). The main focus of this 
paper is to develop a novel multivariate differential coexpression 
analysis approach for gene sets. 
The first approach for testing the differential coexpression of 
gene pairs, tested the equality of pairwise correlations to identify 
gene pairs with correlated expression patterns in one phenotype, 
but not the other (Dawson and Kendziorski, 2012; Fukushima, 
2013; Yu, et al., 2011). Its extension to the general multivariate 
case, involving gene sets with more than 2 genes, depends on the 
biological context. When there are no a priori defined gene sets 
available, the simplest way of differential coexpression analysis, 
implemented in the R package CoXpress, is to find clusters of 
coexpressed genes in one condition and check whether these clus-
ters show no correlation in another condition (Watson, 2006). An-
other approach, e.g., implemented in the R package DiffCoEx, 
constructs adjacency matrices of all genes under different condi-
tions, transforms adjacency matrices into a matrix of adjacency 
differences and uses a topological overlap measure to infer clusters 
of differentially coexpressed genes (Tesson, et al., 2010). When 
there are a priori defined gene sets available, the differential coex-
pression of gene sets can be found by using the gene sets co-
expression analysis (GSCA) (Choi and Kendziorski, 2009). In this 
approach, the Euclidian distance between two correlation vectors 
(constructed from diagonal matrices of pairwise correlations for 
different conditions) is calculated and the significance of the dif-
ference is estimated using permutation test. The differentially co-
expressed gene sets (dCoxS) method is similar to GSCA in its 
overall strategy. First, the gene’s pairwise coexpressions are char-
acterized separately for two conditions and, second, the similarities 
of these characteristics are estimated (Cho, et al., 2009). dCoxS 
uses relative entropy matrices in place of correlation matrices, as 
employed by GSCA, and the correlation coefficient between the 
upper-diagonal elements of these matrices as a measure of their 
similarity. The new property of dCoxS is that the coexpression of 
two different pathways can also be estimated (Cho, et al., 2009). 
There are also other approaches for the differential coexpression 
analysis of gene sets (Emmert-Streib, 2007; Freudenberg, et al., 
2010; Yu and Bai, 2011); the common aspect of all these ap-
proaches is that they account for changes in aggregate measures of 
pairwise correlations only.  
In this paper, we present a novel approach that assesses multivar-
iate changes in the gene coexpression network between two condi-
tions. Importantly, we do not infer ‘gene coexpression networks’ 
explicitly, but, instead, we estimate net correlation changes by 
introducing for each gene a weight factor that characterizes its 
cross-correlations in the coexpression networks. Weight vectors in 
both conditions are found as eigenvectors of correlation matrices 
with zero diagonal elements. The Gene Sets Net Correlations 
Analysis (GSNCA) tests the hypothesis that for a gene set there is 
no difference in the gene weight vectors between two conditions. 
 Furthermore, we suggest a new graphical visualization to pre-
sent the full coexpression network that highlights the most highly 
correlated genes, using the union of the first and second minimum 
spanning trees (MST2). We show that genes in the center of MST2 
have large weights, and we demonstrate that hub genes – genes 
with the largest weight in the pathways – correspond in real data 
frequently to pathway regulators. In previous studies, MST was 
mainly used for cluster analysis in gene expression studies. For 
instance, Xu et al. (Xu, et al., 2001) suggested gene expression 
data clustering based on MST, which rigorously converts a multi-
dimensional clustering problem to a tree partitioning problem. 
Prom-On et al. (Prom-On, et al., 2011) presented a method to im-
prove the biological relevance in the inference of functional mod-
ules from the gene expression data by enhancing the structure of a 
weighted gene coexpression network using MST. However, to our 
knowledge, no attempt has been made so far to present the full 
coexpression network that highlights the most highly correlated 
genes via MST2 structure.  
We choose to compare GSNCA with the gene sets co-expression 
analysis (GSCA) (Choi and Kendziorski, 2009), as the idea behind 
GSCA – comparing pairwise measures of the genes coexpression 
between two conditions - is frequently used in other approaches 
(e.g. dCoxS).  The conceptual differences between our approach 
and GSCA are illustrated in simulations as well as in the applica-
tion to two gene expression data sets. 
2 METHODS 
In the following, we are considering two biological conditions with differ-
ent outcomes, with n1 samples of expression measurements of p genes (that 
form a gene set) for the first, and n2 samples of measurement of the same p 
genes for the second conditions. Let Rl with elements rij denote a p×p gene 
correlation matrix (l=1, 2) for a given condition. Let Nl denote a completely 
connected coexpression network (l=1, 2), with p nodes (genes) and p(p-1)/2 
edges,  where the weight of an edge between any two nodes i and j is given 
by 1- |rij| (correlation distance).  
The organization of this section is as follows: the Gene Sets Net Correla-
tions Analysis (GSNCA) and the gene sets co-expression analysis (GSCA), 
we use for comparison, are explained in Section 2.1. The minimum span-
ning tree approach for the visualization of a backbone of coexpression 
network is given in Section 2.2 and the simulation setup is outlined in 
Section 2.3. Section 2.4 presents the biological datasets we use to demon-
strate the performance of GSNCA and GSCA. All computations in this 
work were implemented using the R (version 2.15.3) computing language. 
 
2.1 Gene Sets Net Correlations Analysis (GSNCA) 
In order to quantitatively characterize the importance of gene i in a correla-
tion network, we introduce a weight (wi) and set wi to be proportional to a 
gene’s cross-correlation with all the other genes. Then, the objective is to 
find a weight vector w, which achieves equality between a gene weight and 
the sum of its weighted cross-correlations for all genes simultaneously. 
Thus, genes with high cross-correlations will have high weights that may 
indicate their regulatory importance. This problem can be formulated as a 
system of linear equations   , 1 
  
 										1 
or equivalently in matrix form     										2. 
This is an eigenvector problem that has a unique solution when the eigen-
value	  1, w>0. Because the matrix    is not guaranteed to 
have eigenvalue	  1, we introduce a multiplicative factor, γ, which 
ensures a proper scaling for eigenvalues and solves the following problem      										3. 
Since the matrix R is non-negative, irreducible, symmetric and has unity 
diagonal elements, its eigenvalues are real and from the Perron-Frobenius 
theorem for non-negative matrices (Meyer, 2001) it follows that R has a 
largest eigenvalue   ∗  1, with a multiplicity of 1, and the other (p-1) 
eigenvalues all satisfy   ∗ for j≠1. This eigenvalue corresponds to a 
unique positive eigenvector v* such that	∗  ∗∗. 
 
Proposition. For a non-negative irreducible correlation matrix R, solving      as an eigenvector problem for w>0 has the unique solution 
w=v* where v* is the positive eigenvector corresponding to the largest real 
eigenvalue of R (λ*). This solution is achievable if the following condition 
is met   	 1∗  1	, ∗  1										4 
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Proof of Proposition. We solve      for w>0 as an eigenvector 
problem where the unique solution is the eigenvector of matrix    
corresponding to "  1. Setting   1 ∗⁄  where ∗  is the 
largest eigenvalue of the matrix    guarantees that the largest eigen-
value of matrix    will be 1, and consequently the corresponding      
eigenvector is the unique solution. Since the matrices R and    have 
the same eigenvectors, the unique solution is w=v*, where v* is the positive 
eigenvector corresponding to the largest eigenvalue of R. Since the eigen-
values of the matrix    are exactly 1 less than the eigenvalues of 
matrix R,   1 ∗⁄  1 ∗  1⁄ , whereas ∗ is the largest eigenvalue 
of R.  
As a test statistic, $%&'(, we use the L1 norm between the scaled weight 
vectors w(1) and w(2) (each vector is multiplied by its norm to scale the 
weight factor values around one) between two conditions,  $%&'( 	∑ +										5-. . 
We use this test statistic to test the hypothesis H0:	$%&'(=0 against the 
alternative H1: $%&'(≠0. P-values for the test statistic are obtained by 
comparing the observed value of the test statistic to its null distribution, 
which is estimated using a permutation approach. We call this test Gene 
Sets Net Correlations Analysis (GSNCA). The GSNCA test is illustrated in 
Fig. 1. We found that the introduced weights are somewhat similar to the 
eigenvector centralities, defined for binary (adjacency) matrices. 
The performance of GSNCA is compared to the performance of Gene 
Sets Co-Expression Analysis (GSCA) (Choi and Kendziorski, 2009). Brief-
ly, GSCA works as follows. For all p(p-1)/2 gene pairs, GSCA calculates 
correlations in the two biological conditions. As test statistic the Euclidean 
distance, adjusted for the size of a gene set is used,  
/$%'(  0 1  1/2  234  34+5+
--/+
4. 										6. 
Here k indexes the gene pairs within the gene set and 34 denotes the corre-
lation of gene pair k in condition i. We would like to note that in this con-
text, the Euclidian distance is similar to the Graph Edit Distance (GED), 
frequently used by methods aiming to detect the differential correlation 
between pathways (Emmert-Streib, 2007). GSCA tests the hypothesis 
H0:	/$%'(=0 against the alternative H1: /$%'(≠0. 
 
2.2 Minimum Spanning Trees 
For a graph G(V,E) where V is the set of vertices and E is the set of edges, 
the first minimum spanning tree (MST) is defined as the acyclic subset 
T1⊆E that connects all vertices in V and whose total length ∑ 9 , ,∈;<  
is minimal. The second MST is defined as the MST of the reduced graph 
G(V, E-T1). The union of the first and second MST (denoted by MST2), 
constructed from using correlation distances, gives the minimal set of es-
sential links (interactions) among genes, which we interpret as a network of 
functional interactions. Each vertex in the MST2 has a minimum degree of 
2 if all the p(p-1)/2 pairwise correlations between genes are considered. A 
gene that is highly correlated with all the other genes tends to occupy a 
central position and has a relatively high degree in the MST2 because the 
shortest paths connecting the vertices of the first and second MSTs tend to 
pass through this gene. In contrast, a gene with low intergene correlations 
most likely occupies a non-central position in the MST2 and has a degree 
of 2. The weight factors, inferred from GSNCA, correlate to some extent 
with genes centralities in the MST2: genes with large weights are placed 
near the center of the MST2, and genes with small weights are placed on 
the periphery (see Section 3.2 for examples).  Adopting network terminolo-
gy, a gene with the largest weight is a hub gene, coexpressed with all the 
other genes in a pathway. In the Results section we illustrate a coexpression 
analysis of gene sets with MST2 and discuss the interpretation of hub 
genes. The MST2 for selected pathways of biological datasets are provided 
in Supplementary Documents 1 and 2. 
 
2.3 Simulation Setup 
To evaluate the performance of GSNCA and GSCA in a fully controlled 
setting, we designed simulation experiments that mimic real expression 
data as close as possible. In a real biological setting, not all genes in a gene 
set are coexpressed, and intergene correlations vary in strength. Therefore, 
we introduced two parameters: γ, the percentage of genes, truly coex-
pressed in a gene set (detection call), and r, the strength of intergene corre-
lation. It is important to understand how exactly these parameters influence 
the power of different tests. 
We simulated two samples of equal size, N/2 (N=40) from p-dimensional 
normal distributions N(0,Σ1) and N(0,Σ2), representing two biological con-
ditions with different outcome. We test the null hypothesis H0:	$%&'(=0, 
where	$%&'( is found from equation (5). Two cases were considered: the 
number of genes in a gene set (pathway) is relatively small (p=20) and 
relatively large (p=100 and p=200). To ensure that Σ1 and Σ2 are positive 
definite, two different scenarios were studied.  
First, Σ1 was set to Ip×p and Σ2 was selected such that its elements are =  >01							
  @, ∀	, @ 
   @, ∀	, @    @.  
For the γ parameter, the proportion of genes truly coexpressed in a gene set, 
we consider γ∈{0.25, 0.5, 0.75, 1}, and for the parameter r, controlling 
the strength of the intergene correlations we consider r∈{0.1, 0.2, …, 
0.9}. Figures 2a and 2b illustrate this setup for p=20 and γ=0.25 where both 
correlation matrices under the alternative hypothesis are shown. Dark and 
light colors represent high and low correlations, respectively. This design 
presents a gene set with low intergene correlations in condition 1 (Fig. 2a) 
Fig. 2. (a and b) The correlation matrices for the first simulation setup in
two conditions with p=20 and γ=0.25. (c and d) The correlation matrices
for the second simulation setup in two conditions with p=20, β=0.25 and 
γ=0.6. Dark and light colors represent high and low correlation values. 
Fig.1. Schematic diagram of GSNCA. Shown are expression samples 
from a single set of k genes in two biological conditions. 
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and one group of highly coexpressed genes in condition 2 (Fig. 2b). The 
purpose of the design is to demonstrate a fundamental difference between 
GSCA and GSNCA. The power of GSCA is expected to increase as r, as 
well as the size of the highly coexpressed group of genes in condition 2, 
increase. Instead, the power of GSNCA is expected to increase as the dif-
ference in intergene correlations between two conditions increases. If all 
genes (γ =1) are highly coexpressed for condition 2, the coexpression ma-
trices in the two conditions are	+      . The eigenvectors for 
both matrices are the same and GSNCA does not detect changes regardless 
of the value of r. The maximum change in the coexpression structure be-
tween condition 1 and 2 using this design occurs when half of the genes (γ 
=0.5) are highly coexpressed in condition 2. That is, GSNCA should have 
the highest power when γ =0.5.  
Second, for both Σ1 and Σ2 we form diagonal blocks of equal size βp, 
where β is the ratio of block size to gene set size (p). Then, for each block 
separately the first scenario is reproduced. Hence, each block will have γβp 
genes with intergene correlation specified by r while all the other genes in 
the block have zero correlations. The locations of the γβp coexpressed 
genes inside each block are assigned differently for Σ1 and Σ2 under alterna-
tive hypothesis. While for Σ1 these genes occupy the upper-left corner of 
the block, for Σ2 they occupy the lower-right corner. Figures 2c and 2d 
illustrate this setup for p=20, β=0.25 and γ=0.6 where both correlation 
matrices under the alternative hypothesis are shown. Dark and light colors 
represent high and low correlations, respectively. Depending on γ, the two 
alternate coexpressed gene groups in Σ1 and Σ2 may have a few common 
genes (when γ>0.5) or may be exclusive (when γ≤0.5). Figures 2c and 2d 
show four common genes between highly coexpressed gene groups. All 
intergene correlations outside the blocks are set to zero or a small value. 
This design presents a gene set with low intergene correlations except for 
selected groups of highly coexpressed genes. The membership of the genes 
in these groups is changing between the two conditions with the possibility 
of having a few common members between the two conditions (when 
γ>0.5). Since the intergene correlation and the structure of the coexpression 
matrix R vary between the two conditions, both GSCA and GSNCA should 
detect changes. 
 
2.4 Biological data 
We illustrate the GSNCA approach using the NCI-60 cell lines (p53) and 
Acute Lymphocytic Leukemia (ALL) datasets. The p53 dataset comprises 
50 samples of NCI-60 cell lines differentiated based on the status of the 
TP53 gene: 17 cell lines carrying normal (wild type, WT) TP53 gene and 
33 cell lines carrying mutated TP53 (MUT) (Olivier, et al., 2002; 
Subramanian, et al., 2005). For this data set probe level intensities were 
quantile normalized and transformed to the log scale. The ALL dataset 
consists of microarrays from 128 different individuals with acute lympho-
blastic leukemia (ALL). There are 95 samples with B-cell ALL (Chiaretti, 
et al., 2004) and 33 with T-cell ALL (Chiaretti, et al., 2005). Tumors, car-
rying the BCR/ABL mutation (37 samples) were compared to those with no 
cytogenetic abnormalities (42 samples). To normalize samples, the robust 
multiarray analysis (RMA) procedure (Irizarry, et al., 2003) was used. 
The microarray platforms for the p53 and ALL datasets are, respectively, 
hgu133plus2 and hgu95av2 with Affymetrix gene identifiers. Genes with-
out mapping to Entrez and Symbol identifiers were discarded. Probes with 
duplicate identities were assessed and the probe with the largest absolute 
value of t-statistic between two conditions was selected as a gene match. 
Gene sets were taken from the C2 pathways set of the molecular signature 
database (MSigDB) (Liberzon, et al., 2011; Subramanian, et al., 2005; Wu 
and Smyth, 2012) where a total of 3272 pathways are present. Pathways 
with less than 15 or more than 500 genes were discarded and the resulted 
dataset comprised 8806 genes and 2360 pathways to analyze. 
3 RESULTS 
3.1 Simulation study 
3.1.1 Type I error rate. Table 1 presents the estimates of the at-
tained significant levels for the GSCA and GSNCA tests (1000 
independent simulations were used). As can be seen, the estimates 
of Type I error rate when Σ1=Σ2=I under different parameter set-
tings for both tests are similar and rather conservative. 
 
Table 1. Type I error rate for GSNCA and GSCA ; α=0.05. 
GSNCA 
GSCA 
p=20 p=60 p=100 
  n1=n2=10 0.054 
0.046 
0.051 
0.048 
0.050 
0.046 
  n1=n2=20 0.050 
0.047 
0.051 
0.048 
0.050 
0.048 
  n1=n2=30 0.049 
0.048 
0.051 
0.051 
0.047 
0.049 
 
 
 
 
Fig. 4. The power curves of GSNCA and GSCA for the second 
simulation setup when the alternative hypothesis is true (N=40). 
 
Fig. 3. The power curves of GSNCA and GSCA for the first simulation 
setup when the alternative hypothesis is true (N=40). 
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3.1.2 The power of tests to detect changes in correlation structure. 
Figure 3 presents power estimates under the first simulation sce-
nario (Section 2.3) for different parameter settings. For each pa-
rameter setting, 1000 independent simulations were used and the 
average (mean) power is shown.  
First, consider the case when 25% of genes in a gene set are co-
expressed (γ=0.25). This is highly plausible for real expression 
data since not many genes in a gene set are highly coexpressed 
(Montaner, et al., 2009; Tripathi and Emmert-Streib, 2012). The 
GSNCA shows higher power than GSCA for all settings (p=20, 
100, 200). Second, consider the case when 50% of genes in a gene 
set are coexpressed (γ=0.5). Both tests show similar power when 
the size of gene set is relatively small (p=20). However, when the 
size of gene set is relatively large (p=100 and p=200) the GSNCA 
outperforms the GSCA. Third, consider the case when 75% of 
genes in a gene set are coexpressed (γ=0.75). GSCA outperforms 
GSNCA when the size of gene set is relatively small (p=20). How-
ever, their performance becomes similar when the number of genes 
increases (p=100, p=200). Fourth, consider the case when 100% of 
genes in a gene set are coexpressed (γ=1). This case illustrates a 
clear-cut difference in performance between GSNCA and GSCA. 
GSNCA has the highest power when γ=0.5 (see Section 2.3 for 
detail). 
Figure 4 presents power estimates under the second simulation 
scenario (see Section 2.3) for different parameter settings. For all 
simulations, we set β=0.25 and used γ={0.6, 0.4, 0.5} for p={20, 
100, 200}, respectively. These simulation parameters result in 3, 
10 and 25 truly coexpressed genes for p=20, 100 and 200, respec-
tively. The results show that GSCA outperforms GSNCA when the 
size of the gene set is relatively small (p=20). When p is 100 an 
opposite trend is observed and when p is further increased to 200 
GSNCA outperforms GSCA. It is also worth noting that when the 
two alternate coexpressed gene groups in Σ1 and Σ2 are exclusive, 
the detection power of GSNCA increases as all genes in both of 
these groups will show high net coexpression change between two 
conditions. Common genes between these groups will have the 
same net coexpression between the two conditions.   
To summarize the simulation results, GSNCA outperforms 
GSCA when the size of gene set is relatively large and when 
changes in coexpression non-uniformly affect pathway members.  
GSCA performs the best when all genes in a pathway are differen-
tially coexpressed. 
 
3.2 P53 dataset 
To study the tests performance we categorized pathways into three 
groups: detected exclusively by GSNCA, exclusively by GSCA 
and by both. The number of pathways detected exclusively by 
GSNCA, GSCA and both were respectively 130, 55 and 15. A 
complete list of these pathways is provided in Supplementary Ta-
ble 1. 
Pathways, found by GSCA and GSNCA approaches fall into 
four major categories: (1) tumorogenesis, (2) monogenic changes 
in tumors, (3) signaling pathways and (4) changes in metabolism. 
In turn, every category can be additionally subdivided into two 
more specific categories: (1) tumor signatures and comparative 
analysis of tumor signatures; (2) fusions and single gene targeting; 
(3) response to anticancer treatment and general system response; 
(4) cellular and nucleic acid metabolisms (Supplementary Table 2). 
GSCA approach finds more pathways, related to metabolism, 
while GSNCA preferentially detects signaling pathways - response 
to anticancer treatment and general system response. The biologi-
cal context of differences between pathways, found exclusively by 
GSNCA and GSCA reflects the difference in null hypotheses, test-
ed by these approaches. GSCA tests the hypothesis that the aver-
aged difference among all pairwise correlations is equal to zero, 
while GSNCA tests that the difference between two weight vec-
tors, corresponding to genes net correlations, is equal to zero.  
Cancer agents act on molecular targets related to p53 that are 
frequently hub genes (see below). Mutation in p53 causes changes 
in targets interactions with the rest of the pathway and consequent-
ly changes in their weights, while overall average correlation for a 
pathway may remain the same. Several aspects of cellular metabo-
lism are also affected by changes in p53 status: p53 has been 
shown to regulate TP53-induced glycolysis, synthesis of cyto-
chrome c oxidase, and damage-regulated autophagy (Jones and 
Thompson, 2009; Vousden and Ryan, 2009). Thus, most metabolic 
networks should be affected by mutated p53 indirectly, through 
reduced nutrient or energy levels, corresponding to changes in 
average correlations between two conditions. 
To illustrate the difference between GSCA and GSNCA ap-
proaches quantitatively, for each set of pathways, detected exclu-
sively by GSNCA, exclusively by GSCA and by both, we found 
(1) the average difference in weight factors between two pheno-
types, WT and MUT (average $%&'() and (2) the difference in 
Fig. 6. MST2s of LU_TUMOR_VASCULATURE_UP coexpression net-
work. (a) MST2 for p53 WT, the hub gene is TNFAIP6 and (b) MST2 for
p53 MUT, the hub is VCAN.  
 
Fig. 5. (a) The difference in average correlations and (b) the average 
difference in weight factors between the two phenotypes detected by 
different approaches for p53 dataset. 
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average correlations between two phenotypes (Fig. 5). Pathways 
detected exclusively by GSNCA or by both tests show higher dif-
ferences in weight factors than pathways detected exclusively by 
GSCA, while pathways detected exclusively by GSCA show high-
er difference in average correlations (Fig. 5). This observation is in 
agreement with our qualitative analysis of biological differences 
between pathways, exclusively detected by different approaches. 
 
3.2.1 Hub genes. GSNCA identifies hub genes – genes with the 
largest weights in each pathway. Hub genes provide useful biolog-
ical information beyond the test result that a pathway is differen-
tially coexpressed between two conditions. In what follows we 
discuss several examples of hubs functional roles in pathways 
identified using GSNCA approach. (MST2 of all significant path-
ways for p53 data and hub genes with corresponding weights are 
provided in Supplementary Document 1). 
Major regulator. LU_TUMOR_VASCULATURE_UP (Fig. 6) 
pathway comprises genes, overexpressed in ovarian cancer endo-
thelium (Lu, et al., 2007). In the original study TNFAIP6 (tumor 
necrosis factor, α-induced protein 6) identified in our analysis as 
hub gene (Fig. 6a), was 29.1 fold overexpressed in tumor endothe-
lium, and was suggested to be specific for ovarian cancer vascula-
ture (Lu, et al., 2007). It indicates that TNFAIP6 can be an im-
portant regulator of ovarian cancer, and its property of being a hub 
enhances the original observation. When p53 is mutated (Fig. 6b) 
hub gene is VCAN, containing p53 binding site. Its expression is 
highly correlated with p53 dosage (Yoon, et al., 2002). Thus, both 
hub genes provide adequate information about the underlying bio-
logical processes. Interestingly, in this example TNFAIP6 has the 
highest degree and betweenness centralities, while VCAN does not 
(data not shown). 
Another interesting example is YAO_HOXA10_TARGETS_ 
VIA_PROGESTERONE_DN pathway (Yao, et al., 2003). The 
authors show that Hoxa-10 mediates proliferation of uterine stro-
mal cells in response to progesterone, and the pathway consists of 
Hoxa-10 down-regulated targets. GSNCA identifies Hoxa-10 as 
hub gene for those targets, in agreement with experimental evi-
dence (Yao, et al., 2003).  
Specific regulator. Trabectedin (ET-743) induces a delay in S 
phase and an arrest in G2/M phase in human cancer cells (Gajate, 
et al., 2002).  GAJATE_RESPONSE_TO_TRABECTEDIN_DN 
pathway (Fig. 7) presents genes, down-regulated in response to 
ET-743. For p53 wild type data, hub gene is STAG1 (stromal anti-
gen 1, Fig. 7a), that encodes a component of cohesin, a multisubu-
nit protein complex that provides sister chromatid cohesion and 
has a specific function in cell division. When p53 is mutated (Fig 
7b), hub gene is CDK14 (cell division protein kinase 14) that con-
trols overall cell cycle progression and cell proliferation. In this 
example, hub genes in both conditions also have highest degree 
and betweenness centralities (data not shown). R package igraph 
(version 0.6.5) was used for network visualization. 
p53 target. p53 is a major tumor suppressor protein, and 44.4% of 
all pathways, found by GSNCA are related to tumorigenesis (Sup-
plementary Table 2). It is logical to assume that p53 and its targets 
(611 genes, www.genecards.org) should be enriched in these 
pathways. Indeed, p53-targets frequently occupy hub positions in 
the case of p-53 WT (hypergeometric test p-value=1.611×10-5). 
This demonstrates that the property of being hub correlates with 
supposed biological function. It should be noted that hub genes in 
pathways detected exclusively by GSCA showed no significant 
enrichment (p-value=0.095) in p53 targets. 
 
 
 
Overall, the analysis of hub genes provides biologically relevant 
information about their role in the underlying processes: it high-
lights genes, major and specific pathways regulators and also genes 
that are affected by global difference between two conditions, in 
this case by mutation in p53 gene. Thus, hub genes can help identi-
fy new biomarkers of tumor progression, metastasis and other 
markers of major phenotypic changes. 
   
3.3 ALL dataset 
For the ALL dataset the number of pathways detected exclusively 
by GSNCA, GSCA and both were respectively 59, 162 and 27. 
Pathways detected exclusively by GSNCA or by both tests again 
show higher differences in the weight factors than the pathways 
detected exclusively by GSCA; differences in the average correla-
tions among the three groups of pathways are less pronounced than 
in the case of p53 data (Fig. 8). A complete list of these pathways 
with their corresponding GSNCA and GSCA p-values is provided 
in Supplementary Table 3. MST2 of all significant pathways for 
Fig. 8. (a) The difference in average correlations and (b) the average 
difference in weight factors between the two phenotypes detected by 
different approaches for ALL dataset. 
 
Fig. 7. MST2s of GAJATE_RESPONSE_TO_TRABECTEDIN_DN  coex-
pression network. (a) MST2 for p53 WT, the hub gene is STAG1 and (b) 
MST2 for p53 MUT, the hub gene is CDK14. 
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ALL data and hub genes with corresponding weights are provided 
in Supplementary Document 2.  
Next, we selected BCR/ABL-related genes (350 genes, 
www.genecards.org) and examined the KEGG_CHRONIC_ 
MYELOID_LEUKEMIA pathway, known to be specifically asso-
ciated with the BCR/ABL mutation. This pathway has 28 
BCR/ABL-related genes (out of 70 genes), resulting in significant 
enrichment (hypergeometric test p-value=3.585×10-21, Supplemen-
tary Table 3). KEGG_CHRONIC_MYELOID_LEUKEMIA was 
detected exclusively by GSNCA with high significance (p-
value=0.005). Although GSCA detects pathways with significant 
differences in correlations, it failed to detect this pathway (p-
value=0.219).  
From the analysis of both datasets we conclude that changes in 
net correlations, overlooked by tests measuring average correlation 
changes, are important and point towards pathways that are cru-
cially involved in phenotypic changes between two conditions. 
4 DISCUSSION 
In this paper, we proposed a new multivariate statistical test, Gene 
Sets Net Correlation Analysis (GSNCA) that detects significant 
changes in the coexpression structure between two different bio-
logical conditions. This represents a major improvement over ear-
lier approaches that compare averaged pairwise correlations, or 
other pairwise measures of coexpression, because our approach is 
able to detect changes previous approaches would miss. This 
strength of GSNCA stems from including all cross-correlations of 
a single gene. In this way, GSNCA is accounting for the multivari-
ate structure of the data. 
The analyses of the p53 and the ALL datasets confirmed that the 
principal difference between GSNCA and GSCA is in the ability of 
the former test to detect pathways with changes in the net correla-
tion structure. For the p53 data set, GSNCA preferentially detects 
signaling pathways - response to anticancer treatment and general 
system response, while GSCA finds more pathways related to me-
tabolism. Anticancer treatments frequently involve cancer agents 
that act on molecular targets such as p53 and p53-related genes. In 
agreement, GSNCA preferentially identifies pathways with p53-
related hub genes (see below) in one phenotype, but not the other, 
reflecting net correlation changes caused by differences in the p53 
status. In turn, GSCA preferentially identifies pathways with aver-
aged correlation changes, as we would expect for metabolic path-
ways affected by p53 status through homeostatic regulation of 
energy and amino acids metabolisms.  Indeed, pathways detected 
exclusively by GSNCA show higher differences in weight factors 
than pathways detected exclusively by GSCA, while pathways 
detected exclusively by GSCA show higher differences in the av-
erage correlations (Fig. 5). For the ALL dataset the difference be-
tween pathways, identified by GSCA and GSNCA is explained 
similarly (Fig. 8). 
GSNCA has an interesting property that we discuss in more de-
tail here. The accurate reconstruction of gene networks from exper-
imental data is considered a major goal of systems biology 
(Stolovitzky, et al., 2007). Depending on the biological context of 
the problem, there are many approaches available (Emmert-Streib, 
et al., 2012), and the most commonly used methods are based on 
correlation measures (Zhang and Horvath, 2005), information-
theoretic approaches (Faith, et al., 2007; Margolin, et al., 2006; 
Meyer, et al., 2007) and probabilistic graphical models (Friedman, 
2004; Friedman, et al., 2000). Our approach does not infer coex-
pression networks, but uses the structure of the full coexpression 
network encoded in its correlation matrix to approximately identify 
changes in coexpression networks between two conditions. Thus, 
GSNCA actually avoids the problem of network inference and gets 
directly to the question that usually motivates the network infer-
ence - what are the differences in coexpression networks. Because 
the network inference step can be computational intense and meth-
od-dependent, this can be a useful property when the research 
question is indeed, the difference between coexpression networks. 
Furthermore, we introduced a new way to visualize coexpression 
networks with all correlations present, employing the union of the 
first and second minimum spanning trees (MST2). MST2 is con-
structed using correlation distance and by construction, genes in 
the center of the MST2 have large weights. The analysis of the p53 
data suggests that genes with large weights - hub genes – have 
interesting biological properties. The hubs frequently correspond to 
pathway regulators and in many cases a functional difference be-
tween hub genes in two conditions reflects the global change un-
derlying the different phenotypes. Actually it is expected, because 
hub genes with large weights may have high degree and between-
ness centralities that are considered to be frequent indicators of 
genes importance (Gu, et al., 2012). Interestingly, the degree and 
betweenness centralities were the highest for hub genes for both 
conditions in one example (Fig. 7), but correlated with high weight 
of hub gene in just one condition in another example (Fig. 6). In 
practice it means that the suggested weights sometimes correlate 
with the centrality measures, but generally characterize node im-
portance differently. Thus, hub genes identified by GSNCA can be 
interesting candidates for further biological studies because, de-
pending on the study, they may represent regulators of tumor pro-
gression, drug targets or critical pathway switches.  
In sum, we presented a novel approach that characterizes differ-
ences in coexpression networks, without requiring the network 
inference step. In general, GSCNA should be a valuable addition to 
GSA approaches because: (1) it identifies differentially coex-
pressed pathways that are overlooked otherwise; (2) eigenvectors 
are computed efficiently and (3) it provides information about the 
importance of genes in pathways that may result in new biological 
hypotheses. 
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